Advanced Search

 

Study ID Status Title Patient Level Data
113635 Completed A Two-part Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a High, Single Oral Dose of GSK1278863 (Part A), and a Randomized, Single-blind, Placebo- and Positive-controlled, Four-way Crossover Study to Assess the Effect of Single, Oral Dose of GSK1278863 on Cardiac Repolarization (Part B) in Healthy Volunteers Study Listed on ClinicalStudyDataRequest.com
113637 Completed Observational study to monitor the introduction of flixotide evohaler in the United Kingdom
113638 Completed Safety and immunogenicity study of GSK Biologicals’ pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 17 years Study Listed on ClinicalStudyDataRequest.com
113639 Completed PEM study on Avandia use
113642 Completed Seretide Evohaler PEM study
113642_1 Completed Seretide Evohaler PEM study
113652 Completed Evaluate (post approval) the adherence to the prescribing information for ARIXTRA® (fondaparinux) in ACS patients- commitment of the fondaparinux EU-RMP
113655 Completed Paroxetine (Paxil®) in relation to birth defects (Slone)
113656 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_1 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_2 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_3 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113656_4 Completed Advair use and risk of COPD hospitalization or mortality in US HMO network
113657 Completed A case control study of lamotrigne and oral clefts
113659 Completed ICS +/- LABA and risk of COPD hospitalization in Kaiser Permanente-Northwest
113659_1 Completed ICS +/- LABA and risk of COPD hospitalization in Kaiser Permanente-Northwest
113659_2 Completed ICS +/- LABA and risk of COPD hospitalization in Kaiser Permanente-Northwest
113660 Completed TZV Epidemiology Program of HSR and Rechallenge HSR: VA
113662 Completed Risk of non-vertebral fracture associated with ICS use in COPD patients in the Veterans Administration healthcare system
113662_1 Completed Risk of non-vertebral fracture associated with ICS use in COPD patients in the Veterans Administration healthcare system
113663 Completed Assessment of incidence and prevalence of pneumonia among COPD patients with or without exposure to inhaled steroids
113663_1 Completed Assessment of incidence and prevalence of pneumonia among COPD patients with or without exposure to inhaled steroids
113665 Completed Risk of non-vertebral fracture associated with ICS use in elderly COPD patients in Quebec
113665_1 Completed Risk of non-vertebral fracture associated with ICS use in elderly COPD patients in Quebec
113665_2 Completed Risk of non-vertebral fracture associated with ICS use in elderly COPD patients in Quebec

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.